Showing results (1251-1260 of 3,886) with videos related to

Sort By:
Pageof 389
Cancer Biology & Therapy|September 22, 2010
Alternative efficacy-predicting markers for paclitaxel instead of CHFR in non-small-cell lung cancerMasafumi Takeshita, Takaomi Koga, Koichi Takayama, et al.
Cancer Biology & Therapy|November 19, 2010
Astrocyte-elevated gene-1 (AEG-1) induction by hypoxia and glucose deprivation in glioblastomaEvan Noch, Markus Bookland, Kamel Khalili
Cancer Biology & Therapy|November 20, 2010
Anticancer activity of Celastrol in combination with ErbB2-targeted therapeutics for treatment of ErbB2-overexpressing breast cancersSrikumar M Raja, Robert J Clubb, Cesar Ortega-Cava, et al.
Cancer Biology & Therapy|November 25, 2010
Co-expression of matrix metalloproteinase-7 (MMP-7) and phosphorylated insulin growth factor receptor I (pIGF-1R) correlates with poor prognosis in patients with wild-type KRAS treated with cetuximab or panitumumab: a GEMCAD studyCarlos Hörndler, Rosa Gallego, Xabier García-Albeniz, et al.
Cancer Biology & Therapy|November 25, 2010
TGFβ-dependent induction of interleukin-11 and interleukin-8 involves SMAD and p38 MAPK pathways in breast tumor models with varied bone metastases potentialJanhavi Gupta, John Robbins, Tamas Jilling, et al.
Cancer Biology & Therapy|December 24, 2010
Autophagy and cancer therapyPaola Maycotte, Andrew Thorburn
Cancer Biology & Therapy|December 24, 2010
ERG oncogene modulates prostaglandin signaling in prostate cancer cellsAhmed A Mohamed, Shyh-Han Tan, Chen Sun, et al.
Cancer Biology & Therapy|June 19, 2010
ZAK is required for doxorubicin, a novel ribotoxic stressor, to induce SAPK activation and apoptosis in HaCaT cellsKristin A D Sauter, Eli A Magun, Mihail S Iordanov, et al.
Cancer Biology & Therapy|July 27, 2010
Werner syndrome as a hereditary risk factor for exocrine pancreatic cancer: potential role of WRN in pancreatic tumorigenesis and patient-tailored therapyStephen G Chun, Nelson S Yee
Cancer Biology & Therapy|July 27, 2010
High levels of fatty acid synthase expression in esophageal cancers represent a potential target for therapyHajime Orita, Jonathan Coulter, Ellen Tully, et al.
Pageof 389